Legal & General Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Sell
42,302
-9,741
-19% -$332K ﹤0.01% 2085
2025
Q4
$2.06M Sell
52,043
-4,849
-9% -$178K ﹤0.01% 1954
2025
Q3
$2.01M Buy
56,892
+136
+0.2% +$4.69K ﹤0.01% 1979
2025
Q2
$1.86M Buy
56,756
+2,056
+4% +$66.8K ﹤0.01% 1990
2025
Q1
$1.76M Sell
54,700
-114
-0.2% -$4.23K ﹤0.01% 1974
2024
Q4
$1.68M Buy
54,814
+4,968
+10% +$160K ﹤0.01% 2053
2024
Q3
$1.4M Buy
49,846
+4,363
+10% +$108K ﹤0.01% 2113
2024
Q2
$1.04M Buy
45,483
+278
+0.6% +$6.42K ﹤0.01% 2185
2024
Q1
$1.38M Buy
45,205
+430
+1% +$14.4K ﹤0.01% 2079
2023
Q4
$1.6M Sell
44,775
-191
-0.4% -$7.1K ﹤0.01% 2054
2023
Q3
$1.97M Buy
44,966
+83
+0.2% +$4.05K ﹤0.01% 1904
2023
Q2
$2.22M Buy
44,883
+2,865
+7% +$132K ﹤0.01% 1876
2023
Q1
$1.74M Buy
42,018
+1,176
+3% +$48.8K ﹤0.01% 1941
2022
Q4
$1.81M Buy
40,842
+1,276
+3% +$53.3K ﹤0.01% 1927
2022
Q3
$1.55M Sell
39,566
-2,242
-5% -$103K ﹤0.01% 1978
2022
Q2
$1.71M Sell
41,808
-206
-0.5% -$9.76K ﹤0.01% 1963
2022
Q1
$2.76M Buy
42,014
+4,507
+12% +$292K ﹤0.01% 1838
2021
Q4
$2.61M Buy
37,507
+108
+0.3% +$7.85K ﹤0.01% 1901
2021
Q3
$2.6M Buy
37,399
+8,390
+29% +$646K ﹤0.01% 1895
2021
Q2
$2.3M Buy
29,009
+6
+0% +$436 ﹤0.01% 1906
2021
Q1
$1.9M Buy
29,003
+19,346
+200% +$1.19M ﹤0.01% 2000
2020
Q4
$537K Sell
9,657
-51
-0.5% -$2.21K ﹤0.01% 2246
2020
Q3
$388K Sell
9,708
-1,159
-11% -$49.1K ﹤0.01% 2248
2020
Q2
$489K Sell
10,867
-318
-3% -$13.8K ﹤0.01% 2175
2020
Q1
$376K Sell
11,185
-671
-6% -$24.1K ﹤0.01% 2147
2019
Q4
$386K Buy
11,856
+1,709
+17% +$48.6K ﹤0.01% 2272
2019
Q3
$253K Buy
10,147
+2,714
+37% +$77.5K ﹤0.01% 2305
2019
Q2
$222K Buy
7,433
+314
+4% +$9.17K ﹤0.01% 2326
2019
Q1
$190K Buy
7,119
+161
+2% +$4.89K ﹤0.01% 2342
2018
Q4
$213K Buy
6,958
+1,646
+31% +$51.3K ﹤0.01% 2286
2018
Q3
$186K Hold
5,312
﹤0.01% 2345
2018
Q2
$143K Sell
5,312
-896
-14% -$21.1K ﹤0.01% 2383
2018
Q1
$127K Sell
6,208
-2,482
-29% -$44.8K ﹤0.01% 2420
2017
Q4
$159K Buy
8,690
+304
+4% +$6.02K ﹤0.01% 2407
2017
Q3
$188K Sell
8,386
-142
-2% -$3.21K ﹤0.01% 2363
2017
Q2
$208K Buy
8,528
+312
+4% +$6.63K ﹤0.01% 2285
2017
Q1
$157K Sell
8,216
-112
-1% -$1.96K ﹤0.01% 2338
2016
Q4
$164K Buy
8,328
+2,861
+52% +$51.9K ﹤0.01% 2313
2016
Q3
$84K Hold
5,467
﹤0.01% 2285
2016
Q2
$78K Hold
5,467
﹤0.01% 2232
2016
Q1
$93K Buy
5,467
+1,282
+31% +$22.6K ﹤0.01% 2097
2015
Q4
$93K Hold
4,185
﹤0.01% 2115
2015
Q3
$88K Hold
4,185
﹤0.01% 2116
2015
Q2
$102K Hold
4,185
﹤0.01% 2101
2015
Q1
$86K Hold
4,185
﹤0.01% 2142
2014
Q4
$82K Hold
4,185
﹤0.01% 2112
2014
Q3
$60K Buy
+4,185
New +$66.7K ﹤0.01% 2277

Other funds holding ATRC

Legal & General Group's ATRC Position: Q1 2026 in Review

Legal & General Group reduced its AtriCure (ATRC) stake by 19% in Q1 2026, selling an estimated $332K and leaving 42,302 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2085.

Legal & General Group first reported a position in ATRC in Q3 2014 and has held it in 47 quarters since. The position peaked at $2.76M in Q1 2022. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Legal & General Group held 42,302 shares of AtriCure worth $1.21M as of Q1 2026.
  • Legal & General Group sold 9,741 AtriCure shares in Q1 2026, an estimated $332K.
  • AtriCure made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2085 holding.
  • Legal & General Group first reported a position in AtriCure in Q3 2014 and has held it in 47 quarters since.
  • Legal & General Group's AtriCure position peaked at $2.76M in Q1 2022.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.